Old Web
English
Sign In
Acemap
>
Paper
>
PH-0053 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial
PH-0053 NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial
2021
O. Vivar
Colette J. Shen
Jessica M. Frakes
J. Niu
A Rosenberg
Jared Weiss
Jimmy J. Caudell
K. Jameson
Patricia Saïd
T. Y. Seiwert
Keywords:
Pembrolizumab
Oncology
Phase (matter)
Medicine
Nivolumab
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]